| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:clvs | nasdaq:clvs Shareholders | 13F-HR | 0001145443-22-000169 | Mar 31st, 2022 12:00AM | May 20th, 2022 12:00AM | May 20th, 2022 12:00AM | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 928047 | CLOVIS ONCOLOGY INC | COM | 189464100 | 107 | 53000 | SH | DFND | 1,2,5 | 0 | 0 | 53000 | May 21st, 2022 01:09AM | May 21st, 2022 01:09AM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:clvs | nasdaq:clvs Shareholders | 13F-HR | 0000749044-22-000003 | Mar 31st, 2022 12:00AM | May 20th, 2022 12:00AM | May 20th, 2022 12:00AM | RESOURCES MANAGEMENT CORP /CT/ /ADV | 749044 | CLOVIS ONCOLOGY INC | Ordinary Share | 189464100 | 1 | 250 | SH | SOLE | 250 | 0 | 0 | May 21st, 2022 01:08AM | May 21st, 2022 01:08AM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:clvs | nasdaq:clvs Shareholders | 13F-HR/A | 0001567619-22-011152 | Mar 31st, 2022 12:00AM | May 18th, 2022 12:00AM | May 18th, 2022 12:00AM | GAMCO INVESTORS, INC. ET AL | 807249 | CLOVIS ONCOLOGY INC COM | COM | 189464100 | 350 | 173050 | SH | SOLE | 173050 | 0 | 0 | May 19th, 2022 01:13AM | May 19th, 2022 01:13AM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:clvs | nasdaq:clvs Shareholders | 13F-HR/A | 0001567619-22-011150 | Mar 31st, 2022 12:00AM | May 18th, 2022 12:00AM | May 18th, 2022 12:00AM | GABELLI FUNDS LLC | 1081407 | CLOVIS ONCOLOGY INC COM | COM | 189464100 | 232 | 114900 | SH | SOLE | 114900 | 0 | 0 | May 19th, 2022 01:13AM | May 19th, 2022 01:13AM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:clvs | nasdaq:clvs Shareholders | 13F-HR/A | 0001166588-22-000018 | Mar 31st, 2022 12:00AM | May 18th, 2022 12:00AM | May 18th, 2022 12:00AM | BNP PARIBAS ARBITRAGE, SA | 1166588 | Clovis Oncology Inc | Equity | 189464100 | 16124 | 7982 | SH | DFND | 1 | 0 | 7982 | 0 | May 19th, 2022 01:12AM | May 19th, 2022 01:12AM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:clvs | nasdaq:clvs Shareholders | 13F-HR | 0001595888-22-000014 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | JANE STREET GROUP, LLC | 1595888 | CLOVIS ONCOLOGY INC | COM | 189464100 | 469 | 232000 | SH | Put | DFND | 2 | 232000 | 0 | 0 | May 18th, 2022 01:13AM | May 18th, 2022 01:13AM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology |
| nasdaq:clvs | nasdaq:clvs Shareholders | 13F-HR | 0001595888-22-000014 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | JANE STREET GROUP, LLC | 1595888 | CLOVIS ONCOLOGY INC | COM | 189464100 | 704 | 348300 | SH | Call | DFND | 2 | 0 | 0 | 0 | May 18th, 2022 01:13AM | May 18th, 2022 01:13AM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology |
| nasdaq:clvs | nasdaq:clvs Shareholders | 13F-HR | 0001595888-22-000014 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | JANE STREET GROUP, LLC | 1595888 | CLOVIS ONCOLOGY INC | COM | 189464100 | 141 | 69573 | SH | DFND | 2 | 69573 | 0 | 0 | May 18th, 2022 01:13AM | May 18th, 2022 01:13AM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:clvs | nasdaq:clvs Shareholders | 13F-HR | 0001595888-22-000014 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | JANE STREET GROUP, LLC | 1595888 | CLOVIS ONCOLOGY INC | COM | 189464100 | 655 | 324337 | SH | DFND | 1 | 324337 | 0 | 0 | May 18th, 2022 01:13AM | May 18th, 2022 01:13AM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:clvs | nasdaq:clvs Shareholders | 13F-HR | 0001172661-22-001498 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | MIRABELLA FINANCIAL SERVICES LLP | 1538853 | CLOVIS ONCOLOGY INC | COM | 189464100 | 36 | 17600 | SH | SOLE | 17600 | 0 | 0 | May 18th, 2022 01:11AM | May 18th, 2022 01:11AM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology |